The Demo site for our new HL7 Version 2+ (plus) Standard
visit the hl7 website

Draft Website - For Review Purposes Only

BPO - Blood Product Order Segment

Blood product order messages require additional information that is not available in other standard HL7 order messages. Blood product order messages need to contain accompanying details regarding the blood product component, such as special processing requirements (e.g., irradiation and leukoreduction) and the amount of the blood product to be administered.

The following table presents various use cases surrounding blood product orders.

Universal Service ID [ISBT-128 Product Code]

Blood Product Processing Requirements

Quantity

Blood Product Amount

Units

002^Red Blood Cells

Leukoreduced

2

Ml

002^Red Blood Cells

Leukoreduced

1

60

Ml

002^Red Blood Cells

Irradiated

2

15

Ml

002^Red Blood Cells

Leukoreduced

1

020^Platelets

Leukoreduced

Irradiated

6

024^ Apheresis Platelets

Irradiated

1

002^Red Blood Cells

1

Factor VIII

2

910

IU


HL7 Attribute Table - BPO - Blood Product Order Segment
Seq# Data Element Name DataType Usage Vocabulary Cardinality Item # Length C.LEN Flags
BPO
1 Set ID – BPO SI R [1..1] 01700 [1..4]
2 BP Universal Service Identifier CWE R [1..1] 01701
3 BP Processing Requirements CWE O [0..*] 01702
4 BP Quantity NM R [1..1] 01703 5 #
5 BP Amount NM O [0..1] 01704 5 #
6 BP Units CWE O [0..1] 01705
7 BP Intended Use Date/Time DTM O [0..1] 01706
8 BP Intended Dispense From Location PL O [0..1] 01707
9 BP Intended Dispense From Address XAD O [0..1] 01708
10 BP Requested Dispense Date/Time DTM O [0..1] 01709
11 BP Requested Dispense To Location PL O [0..1] 01710
12 BP Requested Dispense To Address XAD O [0..1] 01711
13 BP Indication for Use CWE O [0..*] 01712
14 BP Informed Consent Indicator ID O [0..1] 01713 [1..1]

BPO-1: Set ID – BPO (SI) 01700

Definition: This field contains the sequence number for the BPO segment within the message. For the first order transmitted, the sequence number shall be 1; for the second order, it shall be 2; and so on.

BPO-2: BP Universal Service Identifier (CWE) 01701

Definition: This field contains the identifier code for the requested blood product. This can be based on local and/or "universal" codes. We recommend the "universal" procedure identifier. The structure of this CWE data type is described in the control section. The preferred coding system is the ISBT 128 Product Code. Refer to Table 0575 - BP Universal Service Identifier in Chapter 2C for valid values.

Blood Product Orders for commercial products, such as Rh Immune Globulin or Factor VIII concentrate, are not at this time defined in an international or national coding system as are blood products. Therefore, locally defined codes can be used for the Universal Service Identifier for commercial products.

BPO-3: BP Processing Requirements (CWE) 01702

Definition: This field contains additional information about the blood component class associated with the Universal Service ID. The placer of the order can specify any required processing of the blood product that must be completed prior to transfusion to the intended recipient. Refer to User-Defined Table 0508 - Blood Product Processing Requirements in Chapter 2C, Code Tables, for suggested values.

BPO-4: BP Quantity (NM) 01703

Definition: This field contains the number of blood products ordered.

BPO-5: BP Amount (NM) 01704

Definition: This field contains the ordered amount (volume) associated with each quantity of blood product.

BPO-6: BP Units (CWE) 01705

Definition: This field contains the units of measure for the blood product amount. (See Chapter 7 for more details about reporting units.) This field specifies the units of measure for volume of a blood component (i.e., 50 ml) or the units of measure or dosage of a commercial product (i.e., 910 I.U. - International Units - of Factor VIII Concentrate). Use of UCUM is strongly recommended as one of the delivered units (could be in addition to the local units). Refer to Table 0576 - BP Units in Chapter 2C for valid values.

BPO-7: BP Intended Use Date/Time (DTM) 01706

Definition: This field specifies the date/time that the placer intends to use the blood product that is being ordered.

This is the time when the placer expects the product to be available within the transfusion service. For example, the product should be available for use, but not dispensed, on this date/time.

BPO-8: BP Intended Dispense From Location (PL) 01707

Definition: This field contains the location from which the blood component is to be dispensed.

BPO-9: BP Intended Dispense From Address (XAD) 01708

Definition: This field contains the actual address of the location from which the blood component is to be dispensed.

BPO-10: BP Requested Dispense Date/Time (DTM) 01709

Definition: This field specifies the date/time that the requested blood products must be ready to dispense. This date/time may be different from the intended use date/time. For example, the patient may be scheduled to come in for a transfusion at a specified time. However, the placer would request that the blood product be ready to dispense prior to that time in order to have the blood component ready for transfusion at the scheduled time. The field may also be used to indicate that the placer is now ready to pick up the ordered blood product and is requesting the blood product be ready to dispense at that time.

BPO-11: BP Requested Dispense To Location (PL) 01710

Definition: This field contains the inpatient or outpatient location to which the blood component is to be dispensed. The default dispense to location is the current census location for the patient.

BPO-12: BP Requested Dispense To Address (XAD) 01711

Definition: This field contains the actual address of the location to which the blood component is to be dispensed. The default dispense to location is the current census location for the patient.

BPO-13: BP Indication for Use (CWE) 01712

Definition: This is a coded optional field. The value indicates the reason that the blood product was ordered. This information is helpful for prospective review or retrospective studies of blood product ordering practices of the ordering provider by the Quality Assurance Department and/or Transfusion Committee. Refer to User-Defined Table 0509 - Indication for Use in Chapter 2C, Code Tables, for suggested values.

BPO-14: BP Informed Consent Indicator (ID) 01713

This field indicates whether consent for the transfusion has been obtained. Refer to HL7 table 0136 -Yes/No indicator as defined in Chapter 2C, Code Tables.